Advertisement

Impact of Metabolic Control on Cognitive Function and Health-Related Quality of Life in Older Diabetics

  • Anna Marie HerghelegiuEmail author
  • Gabriel Ioan Prada
Chapter
Part of the International Perspectives on Aging book series (Int. Perspect. Aging, volume 10)

Abstract

Type 2 diabetes mellitus has been recognized as another link in the pathological pathways leading to dementia. This field has been discussed in many studies, but clinical research expected to guide medical practice is limited. The main objectives of this study were to evaluate the impact of metabolic profile on cognitive function in older diabetics without dementia and to identify other risk factors associated with cognitive decline and impairment of health-related quality of life (HRQoL). The research was conducted at the National Institute of Gerontology and Geriatrics “Ana Aslan”, Bucharest, during 2008–2011. Three hundred and sixty patients aged 65 and over in the study group and 300 in the control group were evaluated at baseline and every 6 months during an 18-month period. Cognitive function was monitored using the Folstein’s Mini Mental State Examination (MMSE) and the Clock Drawing Test (CDT). HRQoL was examined using the SF-36v2™ standardized questionnaire. The metabolic profile was monitored as well as diabetic complications. Multivariate analyses showed a significant negative relationship between one metabolic parameter, glycated hemoglobin (HbA1c), and cognitive scores in the CDT. Other determinants such as alcohol consumption and body mass index were identified as risk factors for cognitive decline. A significant deterioration in some of the HRQoL domains (such as “role-emotional” and “social role”) was observed in diabetic patients during follow-up. For proper management of an older diabetic patient, routine medical practice should include combined tests for monitoring cognitive function. A good and early metabolic control (confirmed by regular HbA1c tests) contributes to preservation of the cognitive status.

Notes

Acknowledgments

The authors would like to express their deepest gratitude to Professor Alan Walker for his continuous and invaluable guidance and support. They are particularly grateful to Professor Tony Warnes and Professor Stuart Parker for their extremely kind assistance offered during the completion of the FLARE project: “The Impact of Metabolic Control on Cognitive Function and Health Related Quality of Life in Elderly Diabetics.” Moreover, the authors wish to thank Professor Mihail Coculescu for his enthusiastic encouragement and constructive suggestions. Special thanks are conveyed to Dr. Charlotte Ruse, consultant geriatrician at Northern General Hospital, Sheffield, for her generous advice and for being a treasured source of inspiration. Sincere and warm thanks are particularly extended to Dr. Anja Leist for her valuable contribution to improving the quality of the text. Last but not least, cooperation rendered by the funders of this study, Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI), is greatly appreciated.

References

  1. Alencar RC, Cobas RA, Gomes MB (2010) Assessment of cognitive status in patients with type 2 diabetes through the Mini-Mental Status Examination: a cross-sectional study. Diabetol Metab Syndr 2:10CrossRefGoogle Scholar
  2. Alesii A, Mazzarella F, Mastrilli E, Fini M (2007) The elderly and quality of life: current theories and measurements. G Ital Med Lav Ergon 28(Suppl 2):99–103Google Scholar
  3. Alzheimer’s Association (2013) Alzheimer’s disease facts and figures. Alzheimers Dement 9(2):1–71CrossRefGoogle Scholar
  4. Arboleda G, Huang TJ, Waters C et al (2007) Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur J Neurosci 25:3030–3038CrossRefGoogle Scholar
  5. Arvanitakis Z, Wilson RS, Li Y et al (2006) Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29:560–565CrossRefGoogle Scholar
  6. Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer’s disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33(5): 1041–1044CrossRefGoogle Scholar
  7. Biessels GJ, van der Heide LP, Kamal A et al (2002) Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1–14CrossRefGoogle Scholar
  8. Biessels GJ, Staekenborg S, Brunner E et al (2006) Risk of dementia in diabetes: a systematic review. Lancet Neurol 5:64–74CrossRefGoogle Scholar
  9. Binetti G, Magni E, Padovani A et al (1996) Executive dysfunction in early Alzheimer’s disease. J Neurol Neurosurg Psychiatry 60:91–93CrossRefGoogle Scholar
  10. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625CrossRefGoogle Scholar
  11. Cardoso S, Correia SC, Santos RX et al (2013) Hyperglycaemia, hypoglycaemia and dementia: role of mitochondria and uncoupling proteins. Curr Mol Med 13(4):586–601CrossRefGoogle Scholar
  12. Cukierman-Yaffe T, Gerstein H, Williamson J et al (2009a) Relationship between baseline glycaemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Diabetes Care 32:221–226CrossRefGoogle Scholar
  13. Cukierman-Yaffe T, Gerstein HC, Anderson C et al (2009b) Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res Clin Pract 83:387–393CrossRefGoogle Scholar
  14. Dahl Aslan A (2014) Obesity, cognitive ageing, and dementia—the usefulness of longitudinal studies to understand the obesity paradox. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New YorkGoogle Scholar
  15. de la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes: evidence reviewed. J Diabetes Sci Technol 2:1101–1113CrossRefGoogle Scholar
  16. de la Tore JC (2002) Alzheimer disease as a vascular disorder nosological evidence. Stroke 33:1152–1162CrossRefGoogle Scholar
  17. Debette S, Markus HS (2010) The clinical importance of white matter hyper-intensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:1–9CrossRefGoogle Scholar
  18. denHeijer T, Vermeer SE, van Dijk EJ (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46:1604–1610CrossRefGoogle Scholar
  19. Ding J, Strachan MWJ, Reynolds RM et al (2010) Diabetic retinopathy and cognitive decline in older people with type 2 diabetes. The Edinburgh Type 2 Diabetes Study. Diabetes 59(11): 2883–2889CrossRefGoogle Scholar
  20. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–190CrossRefGoogle Scholar
  21. Fuster V, Voute J (2005) MDGs: chronic diseases are not on the agenda. Lancet 366(9496): 1512–1514CrossRefGoogle Scholar
  22. Gandhi GK, Ball KK, Cruz NF, Dienel GA (2009) Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2(2):57–73CrossRefGoogle Scholar
  23. Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer’s disease. Trends Neurosci 26(8):404–407CrossRefGoogle Scholar
  24. Haywood KL, Garratt AM, Fitzpatrick R (2005) Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 14:1651–1668CrossRefGoogle Scholar
  25. Herghelegiu AM, Prada GI (2009) Impactul controlului metabolic asupra functiei cognitive si calitatii vietii la varstnicii diabetici (Rezultate Intermediare)-FLARE PostDoctoral Fellowship. [Impact of metabolic control on cognitive function and health related quality of life in elderly diabetics (intermediate results)]. The 34th National conference of geriatrics and gerontology with international participation—“human aging—between research and geriatric practice,” Bucharest, Romania, 1–4 Oct 2009Google Scholar
  26. Herghelegiu AM, Prada GI (2011) Impactul controlului metabolic asupra functiei cognitive si calitatii vietii la varstnicii diabetici-FLARE PostDoctoral Fellowship. [Impact of metabolic control on cognitive function and health related quality of life in elderly diabetics]. National Conference of Geriatrics and Gerontology, Bucharest, Romania, 12–16 Oct 2011Google Scholar
  27. Hyun Kim D, Newman AB, Hajjar I et al (2011) Retinal microvascular signs and functional loss in older persons: the cardiovascular health study. Stroke 42(6):1589–1595CrossRefGoogle Scholar
  28. Imran Kamarul M, Ismail AAA, Naing L, Wan Mohamad WB (2010) Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J J51(2):157–162Google Scholar
  29. International Diabetes Federation (2011) IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation. http://www.idf.org/diabetesatlas
  30. Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257(1–2):80–87CrossRefGoogle Scholar
  31. Juby A (1999) Correlation between the Folstein Mini-Mental State Examination and three methods of clock drawing scoring. J Geriatr Psychiatry Neurol 12:87–91CrossRefGoogle Scholar
  32. Juby A, Tench S, Baker V (2002) The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. CMAJ 167(8):859–864Google Scholar
  33. Kaffashian S, Dugravot A, Elbaz A et al (2013) Predicting cognitive decline. A dementia risk score vs. the Framingham vascular risk scores. Neurology 80(14):1300–1306CrossRefGoogle Scholar
  34. Kleefstra N, Ubink-Veltmaat LJ, Houweling ST et al (2005) Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med 63:215–221Google Scholar
  35. Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29(4):494–511CrossRefGoogle Scholar
  36. Leist AK, Mackenbach JP (2014) Social, behavioral, and contextual influences on cognitive function and decline over the life course. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New YorkCrossRefGoogle Scholar
  37. Lesage SR, Mosley TH, Wong TY et al (2009) Retinal microvascular abnormalities and cognitive decline. The ARIC 14-year follow-up study. Neurology 73(11):862–868CrossRefGoogle Scholar
  38. Luscombe FA (2000) Health-related quality of life measurement in type 2 diabetes. Value Health 3(1):15–28CrossRefGoogle Scholar
  39. Lyn-Cook LE, Lawton M, Tong M et al (2008) Hepatic ceramide mediates brain insulin resistance and neurodegeneration in obesity with type 2 diabetes mellitus and non-alcoholicsteatohepatitis. J Alzheimers Dis 16:715–729Google Scholar
  40. Manschot SM, Biessels GJ, de Valk H et al (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50:2388–2397CrossRefGoogle Scholar
  41. Mark W, Strachan WJ, Reynolds RM et al (2008) The relationship between type 2 diabetes and dementia. Br Med Bull 88:131–146CrossRefGoogle Scholar
  42. Murray CJL, Lopez AD (eds) (1996) The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard University PressGoogle Scholar
  43. Pinto E, Peters R (2009) Literature review of the Clock Drawing Test as a tool for cognitive screening. Dement Geriatr Cogn Disord 27:201–213CrossRefGoogle Scholar
  44. Prince M, Jackson J (eds) (2009) World Alzheimer Report 2009. Alzheimer’s Disease International, LondonGoogle Scholar
  45. Prince M, Bryce R, Ferri C (eds) (2011) World Alzheimer Report 2011 The benefits of early diagnosis and intervention. Alzheimer’s Disease International, LondonGoogle Scholar
  46. Qiu C (2014) Lifestyle factors in the prevention of dementia: a life-course perspective. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New YorkGoogle Scholar
  47. Roriz-Filho JS, Sá-Roriz TM, Rosset I et al (2009) (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 1792:432–443CrossRefGoogle Scholar
  48. Royall DR, Mulroy AR, Chiodo LK et al (1999) Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol 54B:328–333CrossRefGoogle Scholar
  49. Ryan CM, Geckle MO (2000) Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 23:1486–1493CrossRefGoogle Scholar
  50. Samton JB, Ferrando SJ, Sanelli P et al (2005) The Clock Drawing Test: diagnostic, functional, and neuroimaging correlates in older medically ill adults. J Neuropsychiatry Clin Neurosci 17(4):533–540CrossRefGoogle Scholar
  51. Schlotz W, Ambery P, Syddall HE et al (2007) Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 6(3): 429–436CrossRefGoogle Scholar
  52. Schmidt R, Launer LJ, Nilsson LG (2004) Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53:687–692CrossRefGoogle Scholar
  53. Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community dwelling older persons. Neurology 69:2197–2204CrossRefGoogle Scholar
  54. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 7:4–14CrossRefGoogle Scholar
  55. Speight J, Reaney MD, Barnard KD (2009) Not all roads lead to Rome—a review of quality of life measurement in adults with diabetes. Diabet Med 26:315–327CrossRefGoogle Scholar
  56. Stahelin HB, Monsch AV, Spiegel R (1997) Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Psychogeriatr 9(1):123–130CrossRefGoogle Scholar
  57. Sunderland T, Hill JL, Mellow AM et al (1989) Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. J Am Geriatr Soc 37:725–729Google Scholar
  58. Tiehuis AM, van der Graaf Y, Visseren FL (2008) Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 39:1600–1603CrossRefGoogle Scholar
  59. Tong M, de la Monte SM (2009) Ceramide-mediated neurodegeneration: relevance to Diabetes-associated neurodegeneration. J Alzheimers Dis 16:705–714Google Scholar
  60. Trudeau F, Gagnon S, Massicotte G (2004) Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 490:177–186CrossRefGoogle Scholar
  61. U.K. Prospective Diabetes Study Group (1999) Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 22:1125–1136CrossRefGoogle Scholar
  62. van Harten B, de Leeuw FE, Weinstein HC et al (2006) Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29:2539–2548CrossRefGoogle Scholar
  63. Ware JE, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30(6):473–483CrossRefGoogle Scholar
  64. Whitmer RA, Karter AJ, Yaffe K (2009) Hypoglycaemic episodes and risk of dementia in older patients with type 2 diabetes Mellitus. JAMA 301(15):1565–1572CrossRefGoogle Scholar
  65. Williamson R, McNeilly A, Sutherland C (2012) Insulin resistance in the brain: an old-age or new-age problem? Biochem Pharmacol 84(6):737–745CrossRefGoogle Scholar
  66. Woodford HJ, George J (2007) Cognitive assessment in the elderly: a review of clinical methods. Q J Med 100:469–484CrossRefGoogle Scholar
  67. World Health Organization (2008) The global burden of disease: 2004 update (2008). World Health Organization, Geneva, Switzerland, http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html Google Scholar
  68. Zhao B, Pan BS, Shen SW et al (2013) Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress. J Biol Chem 288(22):15590–15599CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.National Institute of Gerontology and Geriatrics “Ana Aslan”University of Medicine and Pharmacy “Carol Davila”BucharestRomania

Personalised recommendations